Cargando…

National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward

Detalles Bibliográficos
Autores principales:	Cywin, Charles L., Tamiz, Amir P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Current Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722752/ https://www.ncbi.nlm.nih.gov/pubmed/28405931 http://dx.doi.org/10.1007/s13311-017-0530-2

Ejemplares similares

Building Biofoundry India: challenges and path forward
por: Panda, Binay, et al.
Publicado: (2021)

Blueprints for measuring natural behavior
por: Puścian, Alicja, et al.
Publicado: (2022)

A high-stringency blueprint of the human proteome
por: Adhikari, Subash, et al.
Publicado: (2020)

Perspective: Striking a Balance between Planetary and Human Health—Is There a Path Forward?
por: Moreno, Luis A, et al.
Publicado: (2021)

Modern Day Consequences of Historic Redlining: Finding a Path Forward
por: Egede, Leonard E., et al.
Publicado: (2023)

Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

Public health: From politicization to a path forward
por: Udow‐Phillips, Marianne, et al.
Publicado: (2022)

Digital publishing isn't enough: the case for ‘blueprints’ in scientific communication
por: Jennings-Antipov, Laura D., et al.
Publicado: (2018)

Ciliate behavior: blueprints for dynamic cell biology and microscale robotics
por: Coyle, Scott M.
Publicado: (2020)

Female sex in experimental traumatic brain injury research: forging a path forward
por: Currier Thomas, Theresa, et al.
Publicado: (2021)

Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
por: Bayat, Sayeh, et al.
Publicado: (2022)

Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
por: Khatami, Mahin
Publicado: (2016)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Updates and advances in multiple sclerosis neurotherapeutics
por: Amin, Moein, et al.
Publicado: (2022)

Risk of Criminal Justice System Interactions in Young Adults with Attention-Deficit/Hyperactivity Disorder: Findings From a National Birth Cohort
por: Anns, Francesca, et al.
Publicado: (2023)

Three decades of ethical, legal, and social implications research: Looking back to chart a path forward
por: Dolan, Deanne Dunbar, et al.
Publicado: (2022)

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine
por: Illes, Judy, et al.
Publicado: (2017)

Neurosteroids as stress modulators and neurotherapeutics: lessons from the retina
por: Izumi, Yukitoshi, et al.
Publicado: (2022)

Childhood Trajectories of Hyperactivity/Inattention Symptoms and Diurnal Cortisol in Middle Adolescence: Results from a UK Birth Cohort
por: Ji, Dongying, et al.
Publicado: (2021)

National initiatives to promote quality of care and patient safety: achievements to date and challenges ahead
por: Dreiher, Dalia, et al.
Publicado: (2020)

Neuroprotective, neurotherapeutic, and neurometabolic effects of carbon monoxide
por: Mahan, Vicki L
Publicado: (2012)

The social neuroscience of psychosis: From neurobiology to neurotherapeutics
por: Mehta, Urvakhsh Meherwan
Publicado: (2020)

Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy
por: Cardoso, Fabrízio dos Santos, et al.
Publicado: (2022)

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Intra-consortium data sharing in multi-national, multi-institutional genomic studies: gaps and guidance
por: Singh, Jerome Amir, et al.
Publicado: (2009)

Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
por: Postel-Vinay, Sophie, et al.
Publicado: (2020)

The “study” role of past National Institutes of Health study sections
por: Pederson, Thoru
Publicado: (2012)

Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
por: Bagri, Narendra Kumar, et al.
Publicado: (2022)

COVID-19, palliative care and public health
por: Rodin, Gary, et al.
Publicado: (2020)

Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
por: Olson, David E
Publicado: (2018)

Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent
por: Bahbah, Eshak I., et al.
Publicado: (2021)

Biomaterials for Neurotherapeutics: From Lab Discovery to Clinical Application
por: Ao, Qiang
Publicado: (2021)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Neurotherapeutic potential of intranasal administration of human breast milk
por: Malhotra, Atul
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Longitudinal Associations Between COVID-19 Stress and the Mental Health of Children With ADHD
por: Summerton, Ainsley, et al.
Publicado: (2023)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l6mr2reocmin5sa7305559j518